126 related articles for article (PubMed ID: 18051955)
1. Analysis of HLA-G gene expression in B-lymphocytes from chronic lymphocytic leukemia patients.
Rezvany MR; Kazemi A; Hajifathali A; Kaviani S; Mellstedt H
Iran Biomed J; 2007 Apr; 11(2):125-129. PubMed ID: 18051955
[TBL] [Abstract][Full Text] [Related]
2. HLA-G expression in B chronic lymphocytic leukemia: a new prognostic marker?
Erikci AA; Karagoz B; Ozyurt M; Ozturk A; Kilic S; Bilgi O
Hematology; 2009 Apr; 14(2):101-5. PubMed ID: 19298722
[TBL] [Abstract][Full Text] [Related]
3. The significance of soluble HLA-G plasma levels as well as messenger HLA-G for B-cell chronic lymphocytic leukemia (B-CLL).
Giannopoulos K; Schmitt M; Kowal M; Własiuk P; Bojarska-Junak A; Roliński J; Dmoszyńska A
Leuk Res; 2008 Dec; 32(12):1815-9. PubMed ID: 18499249
[TBL] [Abstract][Full Text] [Related]
4. Expression of HLA-G in patients with B-cell chronic lymphocytic leukemia (B-CLL).
Giannopoulos K; Dmoszyńska A; Bojarska-Junak A; Schmitt M; Roliński J
Folia Histochem Cytobiol; 2008; 46(4):457-60. PubMed ID: 19141398
[TBL] [Abstract][Full Text] [Related]
5. Distribution of HLA-G alternative mRNAs including soluble forms in normal lymphocytes and in lymphoid cell-derived leukemia.
Amiot L; Onno M; Drénou B; le Marchand B; Lamy T; Semana G; Fauchet R
Eur J Immunogenet; 1996 Aug; 23(4):311-20. PubMed ID: 8858287
[TBL] [Abstract][Full Text] [Related]
6. HLA-G expression is associated with an unfavorable outcome and immunodeficiency in chronic lymphocytic leukemia.
Nückel H; Rebmann V; Dürig J; Dührsen U; Grosse-Wilde H
Blood; 2005 Feb; 105(4):1694-8. PubMed ID: 15466928
[TBL] [Abstract][Full Text] [Related]
7. NK resistance of tumor cells from multiple myeloma and chronic lymphocytic leukemia patients: implication of HLA-G.
Maki G; Hayes GM; Naji A; Tyler T; Carosella ED; Rouas-Freiss N; Gregory SA
Leukemia; 2008 May; 22(5):998-1006. PubMed ID: 18288133
[TBL] [Abstract][Full Text] [Related]
8. Expression of RHAMM/CD168 and other tumor-associated antigens in patients with B-cell chronic lymphocytic leukemia.
Giannopoulos K; Li L; Bojarska-Junak A; Rolinski J; Dmoszynska A; Hus I; Greiner J; Renner C; Döhner H; Schmitt M
Int J Oncol; 2006 Jul; 29(1):95-103. PubMed ID: 16773189
[TBL] [Abstract][Full Text] [Related]
9. HLA-G expression as a prognostic indicator in B-cell chronic lymphocytic leukemia.
Attia MA; Nosair NA; Gawally A; Elnagar G; Elshafey EM
Acta Haematol; 2014; 132(1):53-8. PubMed ID: 24557341
[TBL] [Abstract][Full Text] [Related]
10. Nurse-like cells show deregulated expression of genes involved in immunocompetence.
Bhattacharya N; Diener S; Idler IS; Rauen J; Häbe S; Busch H; Habermann A; Zenz T; Döhner H; Stilgenbauer S; Mertens D
Br J Haematol; 2011 Aug; 154(3):349-56. PubMed ID: 21615384
[TBL] [Abstract][Full Text] [Related]
11. Prognostic irrelevance of HLA-G in B-cell chronic lymphocytic leukemia.
Perez-Chacon G; Rosado S; Rebolleda N; Losada-Fernandez I; Vargas JA; Morado M; Jorda J; Perez-Aciego P
Int J Lab Hematol; 2009 Jun; 31(3):327-37. PubMed ID: 18241213
[TBL] [Abstract][Full Text] [Related]
12. Total expression of HLA-G and TLR-9 in chronic lymphocytic leukemia patients.
Własiuk P; Tomczak W; Zając M; Dmoszyńska A; Giannopoulos K
Hum Immunol; 2013 Dec; 74(12):1592-7. PubMed ID: 23994589
[TBL] [Abstract][Full Text] [Related]
13. Lymphotoxin beta expression is high in chronic lymphocytic leukemia but low in small lymphocytic lymphoma: a quantitative real-time reverse transcriptase polymerase chain reaction analysis.
Nagy B; Ferrer A; Larramendy ML; Galimberti S; Aalto Y; Casas S; Vilpo J; Ruutu T; Vettenranta K; Franssila K; Knuutila S
Haematologica; 2003 Jun; 88(6):654-8. PubMed ID: 12801841
[TBL] [Abstract][Full Text] [Related]
14. HLA-G in B-chronic lymphocytic leukaemia: clinical relevance and functional implications.
Rebmann V; Nückel H; Dührsen U; Grosse-Wilde H
Semin Cancer Biol; 2007 Dec; 17(6):430-5. PubMed ID: 17683947
[TBL] [Abstract][Full Text] [Related]
15. Activation of HLA-G expression by 5-aza-2 - deoxycytidine in malignant hematopoetic cells isolated from leukemia patients.
Polakova K; Bandzuchova E; Sabty FA; Mistrik M; Demitrovicova L; Russ G
Neoplasma; 2009; 56(6):514-20. PubMed ID: 19728760
[TBL] [Abstract][Full Text] [Related]
16. Determination of HLA-G Expression and Evaluation of Its Role as a Prognostic Factor in Chronic Lymphocytic Leukemia.
Ozet G; Falay M; Dagdas S; Ceran F
J Clin Lab Anal; 2016 Sep; 30(5):399-403. PubMed ID: 26303056
[TBL] [Abstract][Full Text] [Related]
17. Vdelta1 T lymphocytes from B-CLL patients recognize ULBP3 expressed on leukemic B cells and up-regulated by trans-retinoic acid.
Poggi A; Venturino C; Catellani S; Clavio M; Miglino M; Gobbi M; Steinle A; Ghia P; Stella S; Caligaris-Cappio F; Zocchi MR
Cancer Res; 2004 Dec; 64(24):9172-9. PubMed ID: 15604289
[TBL] [Abstract][Full Text] [Related]
18. Frequency analysis of HLA class I alleles in Iranian patients with progressive and non-progressive chronic lymphocytic leukemia.
Hojjat-Farsangi M; Razavi SM; Sharifian RA; Shokri F
Hum Immunol; 2014 Feb; 75(2):170-5. PubMed ID: 24269699
[TBL] [Abstract][Full Text] [Related]
19. Telomerase (hTERT 611-626) serves as a tumor antigen in B-cell chronic lymphocytic leukemia and generates spontaneously antileukemic, cytotoxic T cells.
Kokhaei P; Palma M; Hansson L; Osterborg A; Mellstedt H; Choudhury A
Exp Hematol; 2007 Feb; 35(2):297-304. PubMed ID: 17258078
[TBL] [Abstract][Full Text] [Related]
20. Expression feature of CD3, FcεRIγ, and Zap-70 in patients with chronic lymphocytic leukemia.
Huang L; Chen S; Zha X; Yang L; Li B; Yu Z; Wang L; Li Y
Hematology; 2012 Mar; 17(2):71-5. PubMed ID: 22664044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
